Clinical Trials List
Protocol NumberEFC16313
2024-08-01 - 2029-11-30
Phase III
Recruiting1
ICD-10D59.0
Drug-induced autoimmune hemolytic anemia
ICD-10D59.1
Other autoimmune hemolytic anemias
ICD-9283.0
Autoimmune hemolytic anemias
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
68 participants
